0
0
The Pfizer Covid-19 vaccine may be much more effective in young people aged 5-11 compared to older children and adults, new data found Data collected by health officials in New York State view results in vaccination status among 852,384 children who are fully vaccinated 12-17 years and 365,502 children 5-11 years from December 13, 2022, until January 30, 2022.
They found there was “limited evidence of effectiveness” of the pfizer vaccine in younger children, with effectiveness down to 12% from 68%. In comparison, health officials see a decline in effectiveness that is much smaller in children aged 12-17 years, from 68% to 51% While the Pfizer vaccine offers a slight protection against Covid-19, the vaccine pushes a decrease in inpatient level of 100% to 48%, per set of data “In the omicron era, the effectiveness of the BNT162B2 case decreased rapidly for children, especially those who were 5-11 years,” said health officials in online data posts. “However, the vaccination of children of 5-11 years of protective against severe disease and recommended.”
Pfizer Vaksin Covid-19 may be less effective in young people aged 5-11, new data shows The image filed from the Covid-19 vaccine shot was prepared for the child. Ming Tung / Getty Images Pfizer vaccines may be less effective in young children compared to older children and adults, showing new data Vaccines, which are given in smaller doses to children aged 5-11, are only 12% effective The Pfizer Covid-19 vaccine may be much more effective in young people aged 5-11 compared to older children and adults, new data found.
Data collected by health officials in New York State view results in vaccination status among 852,384 children who are fully vaccinated 12-17 years and 365,502 children 5-11 years from December 13, 2022, until January 30, 2022 They found there was “limited evidence of effectiveness” of the pfizer vaccine in younger children, with effectiveness down to 12% from 68%. In comparison, health officials see a decline in effectiveness that is much smaller in children aged 12-17 years, from 68% to 51%.
While the Pfizer vaccine offers a slight protection against Covid-19, the vaccine pushes a decrease in inpatient level of 100% to 48%, per set of data “In the omicron era, the effectiveness of the BNT162B2 case decreased rapidly for children, especially those who were 5-11 years,” said health officials in online data posts. “However, the vaccination of children of 5-11 years of protective against severe disease and recommended “These results highlight potential needs to study alternative vaccine doses for children and continuation of layered protection, including using masks, to prevent infection and transmission,” he continued.
The Pfizer vaccine is the only vaccine approved for children who are younger than 18 years. The recipient receives a smaller dose than adults, which might point to a lower level of effectiveness than a shot in small children, given a dose that is even smaller than older children or adults The findings of new data came after Pfizer and Biontech requested food and drugs to authorize the covid-19-dose vaccine for children under 5 years. But less than two weeks later, vaccine producers postponed requests after two doses, given at even smaller doses, did not produce a strong immune response in children 6 months to 4 years.
Average Rating